Clinical protocol
NSABP B-51 / RTOG 1304 protocol — A Randomized Phase III Clinical Trial Evaluating Post-Mastectomy Chestwall and Regional Nodal XRT and Post-Lumpectomy Regional Nodal XRT in Patients with Positive Axillary Nodes Before Neoadjuvant Chemotherapy Who Convert to Pathologically Negative Axillary Nodes After Neoadjuvant Chemotherapy
NRG Oncology / NSABP
DoseLab summary
NRG Oncology's protocol page for NSABP B-51 / RTOG 1304, a phase 3 trial of regional nodal irradiation after neoadjuvant chemotherapy. The protocol document holds the trial's normal-tissue requirements.
Why this is useful
Source of the contralateral breast and nodal lung limits cited in DoseLab's breast tables, and the reference eviQ points to when VMAT is used or fields cross the midline.
Reference details
- Title
- NSABP B-51 / RTOG 1304 protocol — A Randomized Phase III Clinical Trial Evaluating Post-Mastectomy Chestwall and Regional Nodal XRT and Post-Lumpectomy Regional Nodal XRT in Patients with Positive Axillary Nodes Before Neoadjuvant Chemotherapy Who Convert to Pathologically Negative Axillary Nodes After Neoadjuvant Chemotherapy
- Authors / organization
- NRG Oncology / NSABP
- Publication / protocol
- Protocol document, NSABP B-51
- Version
- Pending verification
- Year
- Pending verification
- DOI
- Pending verification
- Disease sites
- Breast
- Topics
- Breast, Regional nodes, Post-mastectomy, Dose Constraints, Protocols, NRG
- Fractionation context
- Conventional fractionation, chest wall/breast and regional nodes
- Last reviewed by DoseLab
- Pending verification